Abstract
A series of N-(2-amino-5-substituted phenyl)benzamides (3-21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl)benzamide (6).
Copyright 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Benzamides / chemical synthesis
-
Benzamides / chemistry*
-
Benzamides / toxicity
-
Binding Sites
-
Catalytic Domain
-
Crystallography, X-Ray
-
HCT116 Cells
-
Histone Deacetylase 2 / antagonists & inhibitors*
-
Histone Deacetylase 2 / metabolism
-
Histone Deacetylase Inhibitors / chemical synthesis*
-
Histone Deacetylase Inhibitors / chemistry
-
Histone Deacetylase Inhibitors / toxicity
-
Humans
-
Kinetics
-
Structure-Activity Relationship
Substances
-
Benzamides
-
Histone Deacetylase Inhibitors
-
Histone Deacetylase 2